Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in ...
Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma
Prof Elizabeth Budde - City of Hope, Duarte, USA
Post-HSCT management of ALL - Adult ALL perspective
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
Safety profile of BiTE therapy
Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany
Anti-CD38 immunotherapy treatment for multiple myeloma
Prof Xavier Leleu - CHU de Poitiers, Poitiers, France
Paediatric ALL perspective
Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy
Latest in Philadelphia chromosome-positive ALL (Ph+ ALL)
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
WCLC 2021: Epidemiology of MET Exon 14 mutations
Dr Anna Minchom, Dr Alex Spira, Prof Byoung Chul Cho and Prof Albrecht Stenzinge...
Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatmen...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
Welcome to APCCC 2021
Prof Silke Gillessen and Prof Aurelius Omlin
OncoAlert and ecancer - ESMO 2021 Day 5
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden